✦ LIBER ✦

Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study

✍ Scribed by Auliac, J.B.; Chouaid, C.; Greiller, L.; Monnet, I.; Le Caer, H.; Falchero, L.; Corre, R.; Descourt, R.; Bota, S.; Berard, H.; Schott, R.; Bizieux, A.; Fournel, P.; Labrunie, A.; Marin, B.; Vergnenegre, A.

Book ID: 127074090
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 484 KB
Volume: 85
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2014.07.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Phase III Trial of Erlotinib

Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)

✍ Kawaguchi, T.; Ando, M.; Asami, K.; Okano, Y.; Fukuda, M.; Nakagawa, H.; Ibata, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 183 KB

O-4 A randomized phase II study of docet

O-4 A randomized phase II study of docetaxel versus docetaxel and irinotecan in patients with stage IIIb-IV non-small-cell lung cancer who failed first line chemotherapy

✍ Groen, H.J.M.; Wachters, F.M.; Biesma, B.; Schramel, F.M.N.H.; Stigt, J.A.; Smit 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Randomized Multicenter Phase II Study of

Randomized Multicenter Phase II Study of Gemcitabine Versus Docetaxel as First-Line Therapy with Second-Line Crossover in Advanced-Stage Non–Small-Cell Lung Cancer

✍ Christian Manegold; Lothar Richard Pilz; Gabriele Koschel; Katrin Schott-von Röm 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 158 KB

1307 POSTER First-line chemotherapy with

1307 POSTER First-line chemotherapy with sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer (NSCLC) patients: a multicenter phase II study

✍ C. Tibaldi; E. Vasile; M. Lo Dico; A. Antonuzzo; R. Di Marsico; G. Tartarelli; A 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

First-line chemotherapy with planned seq

First-line chemotherapy with planned sequential administration of cisplatin/gemcitabine followed by docetaxel in elderly ‘unfrail’ patients with advanced non-small-cell lung cancer: a multicenter phase II study

✍ C. Tibaldi, A. Camerini, A. D’Incecco, E. Vasile, A. Fabbri, D. Amoroso, F. Capp 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 174 KB

An open multicenter phase II trial of we

An open multicenter phase II trial of weekly docetaxel for advanced-stage non-small-cell lung cancer in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study

✍ LECAER, H; BARLESI, F; ROBINET, G; FOURNEL, P; GERINIERE, L; BOMBARON, P; FALCHE 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 179 KB